BioSpace News Archive

BioCapital

NexImmune to Present at The Society for Immunotherapy of Cancer 36th Anniversary Annual Meeting

NexImmune, Inc. today announced that two abstracts have been accepted for poster presentation at the upcoming Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting in Washington, D.C., being held November 10-14, 2021.

November 3, 2021
·
4 min read
Business

Resverlogix Enters into a Cooperation Agreement with the Supreme Council of the Arab-African Economy to Support the Development of Apabetalone for COVID-19 Patients

Resverlogix Corp. is pleased to announce today that it has entered into a cooperation agreement with the Supreme Council of the Arab-African Economy

November 3, 2021
·
6 min read
Business

Daré Bioscience to Host Third Quarter 2021 Financial Results and Company Update Conference Call and Webcast on November 10, 2021

Daré Bioscience, Inc. today announced that it will host a conference call and live webcast at 4:30 p.m. Eastern Time on Wednesday, November 10, 2021, to review its financial results for the quarter ended September 30, 2021 and to provide a Company update.

November 3, 2021
·
2 min read
Deals

Timber Pharmaceuticals Announces Pricing of $15 Million Public Offering

Timber Pharmaceuticals, Inc. today announced the pricing of its previously announced underwritten public offering of 23,437,500 shares of its common stock

November 3, 2021
·
5 min read
Policy

AstraZeneca Canada Files for Health Canada Authorization of AZD7442 for Prevention Of COVID-19

AstraZeneca Canada has initiated a rolling review New Drug Submission with Health Canada for authorization of AZD7442, its long-acting antibody combination, for prevention of symptomatic COVID-19.

November 3, 2021
·
6 min read
Biond Biologics Announces Closing of $15 Million Series C Financing

Biond Biologics Ltd. announced today the closing of a $15 million, Series C financing round.

November 3, 2021
·
3 min read
Biotech Beach

Inhibrx Announces Presentations at SITC 2021

Inhibrx, Inc. announced today that the Company will be presenting three poster presentations at the Society for Immunotherapy of Cancer’s (SITC) annual meeting, to be held in Washington, D.C.

November 3, 2021
·
2 min read
Lone Star Bio

Data from ImmunoGenesis’ Lead Programs to be Presented at Society for Immunotherapy of Cancer (SITC) Conference

ImmunoGenesis today announced the acceptance of six poster presentations on its lead development programs at the Society for Immunotherapy of Cancer 36 th Annual Meeting (SITC 2021), which will be held November 10-14, 2021 , in Washington, DC

November 3, 2021
·
3 min read
Pharm Country

INOVIO Further Expands INNOVATE Phase 3 Trial for COVID-19 DNA Vaccine Candidate INO-4800 With Regulatory Authorization from India

Authorization to conduct INNOVATE Phase 3 trial in India builds on recent regulatory authorizations from Brazil, Philippines, Mexico and Colombia

November 3, 2021
·
8 min read
Pharm Country

Geistlich Pharma Launches Geistlich Nexo-Gide® Dual Surface Membrane for Tendon Management and Protection

The Geistlich Surgery, USA business unit of Geistlich Pharma AG, a family owned, Swiss-based global leader in regenerative solutions, is proud to announce the launch of its latest advancement: Geistlich Nexo-Gide® Dual Surface Membrane.

November 3, 2021
·
2 min read